Elevation Wealth Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187K Sell
668
-13
-2% -$3.42K 0.06% 144
2026
Q1
$182K Sell
681
-2
-0.3% -$542 0.07% 123
2025
Q4
$171K Sell
683
-80
-10% -$21.2K 0.06% 126
2025
Q3
$219K Buy
763
+3
+0.4% +$804 0.08% 110
2025
Q2
$200K Hold
760
0.08% 113
2025
Q1
$177K Hold
760
0.08% 122
2024
Q4
$174K Hold
760
0.07% 124
2024
Q3
$170K Hold
760
0.07% 126
2024
Q2
$155K Hold
760
0.07% 129
2024
Q1
$166K Hold
760
0.08% 123
2023
Q4
$153K Buy
+760
New +$160K 0.09% 117

Other funds holding LH

Elevation Wealth Partners's LH Position: Q2 2026 in Review

Elevation Wealth Partners reduced its Labcorp (LH) stake by 1.9% in Q2 2026, selling an estimated $3.42K and leaving 668 shares worth $187K. The position accounts for 0.06% of the portfolio, ranked #144.

Elevation Wealth Partners first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $219K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Elevation Wealth Partners held 668 shares of Labcorp worth $187K as of Q2 2026.
  • Elevation Wealth Partners sold 13 Labcorp shares in Q2 2026, an estimated $3.42K.
  • Labcorp made up 0.06% of Elevation Wealth Partners's portfolio in Q2 2026, its #144 holding.
  • Elevation Wealth Partners first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Elevation Wealth Partners's Labcorp position peaked at $219K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.